Global Thrombin (Human) Market Growth 2025-2031

The global Thrombin (Human) market size is predicted to grow from US$ 589 million in 2025 to US$ 714 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Thrombin (Human) Industry Forecast” looks at past sales and reviews total world Thrombin (Human) sales in 2024, providing a comprehensive analysis by region and market sector of projected Thrombin (Human) sales for 2025 through 2031. With Thrombin (Human) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thrombin (Human) industry.

This Insight Report provides a comprehensive analysis of the global Thrombin (Human) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thrombin (Human) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thrombin (Human) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thrombin (Human) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thrombin (Human).

This report presents a comprehensive overview, market shares, and growth opportunities of Thrombin (Human) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
500IU/Vial
1000IU/Vial
2500IU/Vial

Segmentation by Application:
Biotechnology
Medicine
Microbiology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Kedrion

Key Questions Addressed in this Report

What is the 10-year outlook for the global Thrombin (Human) market?

What factors are driving Thrombin (Human) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Thrombin (Human) market opportunities vary by end market size?

How does Thrombin (Human) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.